Pharmaids Pharmaceuticals Limited (BOM:524572)
India flag India · Delayed Price · Currency is INR
42.46
-1.79 (-4.05%)
At close: Jan 23, 2026

Pharmaids Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jan '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
1,4972,4221,834489129115
Upgrade
Market Cap Growth
-45.92%32.06%275.20%278.93%11.90%148.44%
Upgrade
Enterprise Value
1,6902,5151,825494128115
Upgrade
Last Close Price
42.4668.6752.0021.8112.5111.18
Upgrade
PE Ratio
----88.87123.54
Upgrade
PS Ratio
6.0412.4111.99-3.281.35
Upgrade
PB Ratio
2.924.402.602.181.491.35
Upgrade
P/TBV Ratio
7.308.854.582.181.491.35
Upgrade
P/FCF Ratio
-----28.55
Upgrade
P/OCF Ratio
-----28.44
Upgrade
EV/Sales Ratio
6.8112.8911.93-3.251.34
Upgrade
EV/EBITDA Ratio
----94.04107.12
Upgrade
EV/EBIT Ratio
----100.22184.45
Upgrade
EV/FCF Ratio
-5.84----28.36
Upgrade
Debt / Equity Ratio
0.390.710.12---
Upgrade
Asset Turnover
0.260.190.26-0.390.97
Upgrade
Inventory Turnover
5.231.68--5.68-
Upgrade
Quick Ratio
0.300.180.658.530.720.81
Upgrade
Current Ratio
0.810.781.178.621.091.46
Upgrade
Return on Equity (ROE)
-26.91%-21.52%-25.48%-48.54%1.69%1.10%
Upgrade
Return on Assets (ROA)
-12.78%-8.94%-14.92%-34.69%0.79%0.44%
Upgrade
Return on Capital Employed (ROCE)
-28.80%-16.60%-17.30%-44.10%1.50%0.70%
Upgrade
Earnings Yield
-8.86%-4.45%-4.35%-15.46%1.13%0.81%
Upgrade
FCF Yield
-19.32%-10.93%-18.26%-11.65%-2.01%3.50%
Upgrade
Buyback Yield / Dilution
-38.67%-55.24%-76.16%-25.07%--
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.